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Protein family review
The MAP2/Tau family of microtubule-associated proteins
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Summary
Microtubule-associated proteins (MAPs) of the MAP2/Tau family include the vertebrate proteins
MAP2, MAP4, and Tau and homologs in other animals. All three vertebrate members of the
family have alternative splice forms; all isoforms share a conserved carboxy-terminal domain
containing microtubule-binding repeats, and an amino-terminal projection domain of varying size.
MAP2 and Tau are found in neurons, whereas MAP4 is present in many other tissues but is
generally absent from neurons. Members of the family are best known for their microtubule-
stabilizing activity and for proposed roles regulating microtubule networks in the axons and
dendrites of neurons. Contrary to this simple, traditional view, accumulating evidence suggests a
much broader range of functions, such as binding to filamentous (F) actin, recruitment of signaling
proteins, and regulation of microtubule-mediated transport. Tau is also implicated in Alzheimer’s
disease and other dementias. The ability of MAP2 to interact with both microtubules and F-actin
might be critical for neuromorphogenic processes, such as neurite initiation, during which
networks of microtubules and F-actin are reorganized in a coordinated manner. Various
upstream kinases and interacting proteins have been identified that regulate the microtubule-
stabilizing activity of MAP2/Tau family proteins. 
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Gene organization and evolutionary history 
Several types of microtubule-associated protein (MAP) have
evolved in eukaryotes, including microtubule motors, micro-
tubule plus-end-binding proteins, centrosome-associated
proteins, enzymatically active MAPs, and structural MAPs.
We focus here on the MAP2/Tau family of structural MAPs,
which along with the MAP1A/1B family form one of the ‘clas-
sical’, well-characterized families of MAPs. In mammals, the
family consists of the neuronal proteins MAP2 and Tau and
the non-neuronal protein MAP4 (Table 1). 
It has been proposed that the Escherichia coli protein ZipA,
which interacts with the bacterial tubulin homolog FtsZ [1],
might be an ancient prototype of MAP2/Tau family
members [2]. ZipA contains a region with limited homology
to MAP2/Tau proteins, but this region is neither sufficient
nor necessary for FtsZ binding [3]. A single, unambiguous
functional ortholog of MAP2/Tau proteins is found in
Caenorhabditis elegans (alternative splice forms PTL-1A
and PTL-1B [4,5]) and in Drosophila melanogaster
(CG31057 [6]; see Figure 1). Both contain microtubule-
binding domains related to those in mammalian MAP2/Tau
proteins. In contrast, the genome of the frog Xenopus laevis
has an ortholog of each member of the family. At least three
distinct MAP2/Tau related genes have been identified in the
Tetraodon (pufferfish) genome: CAF98218 and CAG09246
appear similar to MAP2, whereas CAG03020 appears
similar to Tau [7]. Additional MAP2/Tau-related genes
appear to be present in Tetraodon, but the limited sequence
information and lack of mapping data make it difficult to
evaluate their significance. No homologs have been found in
eukaryotes outside animals. Mammalian MAP2/Tau genes
span multiple exons, which are spliced to produce several
alternative isoforms [8,9] (Table 1 and see below). Characteristic structural features 
All MAP2/Tau family proteins have microtubule-binding
repeats near the carboxyl terminus [10], each containing a
conserved KXGS motif that can be phosphorylated (Figure
2) [11,12]. In addition, each family member contains an
amino-terminal projection domain of varying size. In MAP2
and Tau, this domain has a net negative charge and exerts a
long-range repulsive force as shown by atomic force
microscopy [13]. Each protein has several isoforms, with
variation in the length of the projection domain and the
number of microtubule-binding repeats [8,9]. The main
forms of MAP2 are MAP2c, which is relatively short, and
MAP2a and MAP2b, which have longer projection domains.
MAP2/Tau family members are natively unfolded molecules
and, like other proteins in this class, are thought to adopt
specific conformations upon binding to their targets (micro-
tubules, F-actin and potentially other molecules) [14]. Most
regions of MAP2/Tau proteins seem to be devoid of sec-
ondary structure. The only region of MAP2 that appears to
form a secondary structure is an amino-terminal domain
(residues 86-103), which is found in all isoforms and inter-
acts with the regulatory subunit of protein kinase A (PKA).
Like the related domain in the A-kinase anchoring protein
AKAP79/150, this region is predicted to form an amphi-
pathic helix [15]. 
MAP2 also can interact directly with F-actin [16]; interest-
ingly, the F-actin-binding site is located within the domain
containing the microtubule-binding repeats. Although the
MAP2 repeat region is highly similar to that of Tau,
neither wild-type Tau nor MAP2 chimeras containing the
Tau microtubule-binding repeats can bind to F-actin
directly. However, F-actin binding is conferred on Tau if
its microtubule-binding domain is exchanged for the cor-
responding region of MAP2 [16]. 
Localization and function 
Developmental and regional expression 
Mammalian MAP2 is expressed mainly in neurons, but
MAP2 immunoreactivity is also detected in some non-neu-
ronal cells such as oligodendrocytes. Its expression is very
weak in neuronal precursors and then becomes strong about
1 day after expression of neuron-specific tubulin isoform βIII
[17]. MAP2c is the juvenile isoform and is downregulated
after the early stages of neuronal development [18], whereas
MAP2b is expressed both during development and adult-
hood. MAP2a becomes expressed when MAP2c levels are
falling and is not detected uniformly in all mature neurons
[19]. In the brain, smaller splice forms of Tau (of 50-65 kDa)
are differentially expressed during early development.
Specifically, Tau isoforms with three microtubule-binding
repeats are predominantly expressed during early develop-
ment, whereas isoforms with four repeats are expressed
during adulthood [20,21]. High-molecular-weight variants
of Tau (110-120 kDa) are expressed in peripheral neurons
and also at a much lower level in the brain [22]. MAP4 is
expressed in various organs, including brain, adrenal gland,
lung and liver [23], but it is not ubiquitously expressed: in
the brain, for example, MAP4 is expressed only in non-
neuronal cells and is absent from neurons [24].
Shortly after axonogenesis in developing cortical and hip-
pocampal neuronal cultures, Tau gradually segregates into
axons, while MAP2 segregates into the nascent dendrites (at
this stage dendrite precursors are called ‘minor neurites’)
[25]. It is believed that a combination of protein stability
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Table 1
Properties of human MAP2/Tau family genes
Gene Locus Predicted exons Splice form Number of microtubule-binding repeats Alternatively spliced exons
MAP2 2q34-q35 18 Isoform 1 (MAP2b) 3 +9, +10, +11, -16
Isoform 2 (MAP2c) 3 -9, -10, -11, -16
Isoform 3 4 +9, +10, +11, +16
Isoform 4 (MAP2d) 4 -9, -10, -11, +16
MAP2a Unknown +8, +9, +10, +11, (16?)
Tau 17q21.1 17 Isoform 1 (HMW-tau) 4 +2, +3, +4A, +6, +10
Isoform 2 (tau 4R/2N) 4 +2, +3, -4A, -6, +10
Isoform 3 (tau 4R/0N) 4 -2, -3, -4A, -6, +10
Isoform 4 (tau 3R/0N) 3 -2, -3, -4A, -6, -10
MAP4 3p21 23 Various isoforms 3-5 Various
Chromosomal localization and sequence information about reviewed alternative splice forms were obtained from LocusLink [75]. Commonly used
designations for splice forms are indicated in brackets.c
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Figure 1 
Phylogenetic analysis of MAP2/Tau family proteins. Homologous protein
sequences of the microtubule-binding repeats of MAP2 (using splice forms
(with three microtubule-binding repeats), Tau (four-repeat isoforms),
MAP4 (five-repeat isoforms) and the invertebrate MAPs CG31057 and
PTL-1A (five-repeat isoforms) were analyzed using the program Phylip
[76]; gaps were ignored. The available Tetraodon sequences are
incomplete and were therefore not included in the analysis.
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Figure 2 
The domain organization of MAP2/Tau family proteins. Selected isoforms
of the human members of the family are shown, as well as the nematode
homolog PTL-1. All family members have alternative splice forms with
varying numbers of carboxy-terminal microtubule-binding repeats and
amino-terminal projection domains of varying lengths. PKA (RII) indicates
a domain interacting with the RII subunit of protein kinase A. Repeats that
are not present in all major isoforms are shown lighter.
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[26], differential protein sorting [27], and dendrite-specific
transport of MAP2 mRNA [28] are responsible for this
spatial segregation of the two MAPs. Thus, in mature
neurons Tau is present mainly in axons whereas MAP2 is
restricted to cell bodies and dendrites (Figure 3). 
Functions of MAP2 and Tau in neurons  
MAP2/Tau family proteins were originally discovered for and
characterized by their ability to bind and stabilize micro-
tubules. Ultrastructural analyses revealed the presence of
these MAPs along the sides of microtubules [29-31]. MAP2
and Tau also increase microtubule rigidity [32] and induce
microtubule bundles in heterologous cell systems [33-35].
Microtubule bundle formation induced by MAP2 was sug-
gested to be an indirect effect of its stabilization of micro-
tubules within the confinement of cell borders [36], but more
recent results suggest that MAP2-induced bundles can form
even within the interior of the cell [37], indicating the
existence of crosslinks. Evidence for direct crosslinking of
microtubules by MAP2/Tau family proteins is lacking, leaving
open the possibility that additional proteins are necessary. 
As described above, MAP2 can bind both microtubules and
F-actin, and both activities have been mapped to its micro-
tubule-binding-repeat domain. It is not yet known whether
a single molecule can crosslink an actin filament to a
microtubule. MAP2 can bundle actin filaments in vitro [16].
MAP2c by itself can induce neurites in Neuro-2a neuroblas-
toma cells; its microtubule-stabilizing activity is necessary
for this effect but is not sufficient, and F-actin dynamics also
need to be altered [38]. MAP2’s ability to interact with F-
actin appears to be key to this specific biological function.
Unlike MAP2c, neither Tau nor chimeric MAP2c containing
the Tau microtubule-binding domain can trigger neurite ini-
tiation, an observation that correlates with their lack of F-
actin binding in vitro [16]. This suggests that MAP2c’s
ability to interact with both microtubules and F-actin is
essential for its neurite-initiation activity.
Knockout experiments in mice suggest that neither MAP2
nor Tau is essential by itself, but each single knockout leads
to detectable morphological phenotypes. Tau expression
was undetectable after targeted deletion of the first Tau
exon, which includes the protein start codon [39]. Homozy-
gous animals showed no major defects in brain morphol-
ogy, but the microtubule density in small-caliber axons was
reduced. Similarly, MAP2 expression was undetectable
after deletion of one exon encoding a portion of the MAP2
microtubule-binding domain [40]. Again, homozygousanimals showed no major defects in brain morphology, but
microtubule density in dendrites was reduced. In addition,
dendrite length in cultured neurons was reduced, suggesting
a role for MAP2 in supporting dendrite elongation.
The phenotypes of single knockouts suggest specific but
nonessential roles for Tau and MAP2 in the morphogenesis
of the nervous system. However, these proteins probably
have multiple roles in other pathways and can be compen-
sated for by other proteins with redundant functions. Inter-
estingly, the structurally unrelated microtubule-associated
protein MAP1B appears to have some redundant roles with
both Tau [41,42] and MAP2 [43]. Simultaneous inhibition of
either MAP1B and Tau or MAP1B and MAP2 resulted in
more severe phenotypes than those seen in single knockouts.
Taken together, these experiments suggest a role for Tau,
MAP2 and MAP1B in both neuronal migration and out-
growth of neurites. Redundancy among MAP2, Tau and
MAP4 has not been adequately tested in mammalian
systems. It is also possible that other classes of MAP such as
stable tubule only protein (STOP), adenomatous polyposis
coli (APC), doublecortin, or spectraplakins might provide
additional redundancy with MAP functions.
MAP2/Tau family proteins have been shown to interact
with numerous proteins; Table 2 provides an overview of
identified interaction partners and briefly describes the
proposed function of each interaction. Binding of MAP2 to
the RII regulatory subunit of PKA is one of the best-charac-
terized examples of a classical MAP functioning as an
adaptor protein. The interaction site was mapped to the
amino terminus of MAP2 and is present in all common
MAP2 splice forms in mammals [44] but absent in Tau.
Knockout mice show that MAP2 is essential for linking PKA
to microtubules in various brain regions [40]. Interestingly,
the absence of MAP2 affects the phosphorylation of cAMP-
responsive element binding protein (CREB), suggesting a
role for the MAP2-PKA interaction in CREB-mediated
signal transduction [40]. Deletion of the PKA-binding site
in MAP2c reduces its ability to induce neurites in neuro-
blastoma cells [38]. 
Tau has been studied extensively for its involvement in
neurofibrillary tangle formation in Alzheimer’s Disease and
in frontotemporal dementias associated with chromosome
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Figure 3
A neuron from a culture of rat brain hippocampus, showing the distinct
subdomains of MAP2 and Tau enrichment in mature neurons. MAP2 is
found specifically in dendrites (arrow), whereas Tau is mainly axonal
(arrowhead). Note the fine meshwork of axons from neighboring cells
outside the field of view that make numerous synaptic connections among
the neurons in the culture.17 (FTDP-17); see several excellent discussions of Tau
pathology [45-48].
Functions of MAP4 and non-neuronal functions of
MAP2 and Tau  
The widely expressed non-neuronal member of the
MAP2/Tau family, MAP4, shares many features with other
members of the family, including the presence of micro-
tubule-binding repeats [49] and microtubule-stabilizing
activity [50]. MAP4 has been proposed to play a role in reg-
ulating mitotic microtubule dynamics during metaphase
[51]. However, using function-blocking antibodies that
interfere with the MAP4-microtubule interaction, a more
recent study [52] failed to detect an obvious phenotype in
mitosis or during interphase, suggesting that MAP4 might
be a component of a functionally redundant system.
Muscle-specific MAP4 isoforms have been shown to be
required for myogenesis [53], but the exact role of MAP4 is
not known in this process.
Although MAP2 is primarily neuronal, some isoforms are
also present in certain astrocytes [54], oligodendrocytes
[55], as well as in the testis [56]. The testicular isoform of
MAP2 contains a functional nuclear localization sequence
[56] and is enriched in nuclei of germ cells. Like MAP2, the
primarily neuronal Tau is also expressed in oligodendrocytes
[57]. Interestingly, alternative splicing of MAP2 [55] and
Tau [58] is similar during the maturation of oligodendro-
cytes and neurons. In oligodendrocytes, Tau and its regula-
tion by the Fyn tyrosine kinase are proposed to be involved
in process outgrowth [59].
Mechanism and regulation  
Microtubules exhibit dynamic instability, an intrinsic behav-
ior characterized by alternating phases of growth, shorten-
ing, and pausing. The switch from growth to shortening and
the switch from shortening to growth are called catastrophes
and rescues, respectively. MAP2/Tau proteins bind along the
length of microtubules and stabilize microtubules by altering
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
http://genomebiology.com/2004/6/1/204                                           Genome Biology 2004, Volume 6, Issue 1, Article 204 Dehmelt and Halpain  204.5
Genome Biology 2004, 6:204
Table 2 
Selected interaction partners of MAP2/Tau family proteins
Family member Interacting protein Proposed function of the interaction Reference
MAP2 Microtubules  Stabilization of microtubules; inhibition of depolymerization (catastrophes);  [77]
increase in microtubule rigidity, neurite initiation
F-actin  Modulation of neurite initiation [16]
Regulatory subunit RII of PKA  Localization of PKA to hippocampal dendrites; facilitation of cAMP-responsive  [44]
element binding protein (CREB) phosphorylation; modulation of neurite initiation
Tyrosine kinase Src  Signal transduction and integration [78]
Adapter protein Grb2  Signal transduction and integration [78]
Tyrosine kinase Fyn Signal transduction and integration [79]
Neurofilaments Crossbridges between microtubules and neurofilaments [80]
Class C L-type calcium channels Linking PKA to channels [81]
MAP2-RNA trans-acting proteins  Interaction with MAP2 mRNA: targets MAP2 mRNA to dendrites [82]
MARTA1 and MARTA2
Tau Microtubules  Stabilization of microtubules; inhibition of depolymerization (catastrophes);  [83]
increase in microtubule rigidity
Fyn  Modulation of microtubule organization; pathogenesis of Alzheimer’s disease [84]
Src Unknown [84]
Presenilin 1 Links Tau to glycogen synthase kinase 3β; pathogenesis of Alzheimer’s disease [85]
Apolipoprotein E Regulation of Tau metabolism; pathogenesis of Alzheimer’s disease [86]
Calmodulin  Regulation of microtubule assembly  [87]
Calmodulin-related protein S100b Regulation of Tau phosphorylation by protein kinase C [87]
MAP4 Microtubules  Stabilization of microtubules; inhibition of depolymerization (catastrophes) [49]
Cyclin B  Links p34cdc2 kinase to microtubules; regulation of M-phase microtubule dynamics [51]this dynamic behavior [31,60,61]. The small isoform MAP2c
stabilizes microtubules primarily by reducing the frequency
and duration of catastrophes [60]. Under conditions where
its concentration is non-saturating, MAP2 can also form
clusters on microtubules, and microtubule catastrophes
stop at such clusters [62]. Interestingly, isoforms of Tau
containing three or four microtubule-binding repeats have
distinct effects on microtubule dynamics, with four-repeat
isoforms protecting microtubules from depolymerization
much more robustly than three-repeat isoforms [61]. In
cells, microtubules still exhibit dynamic behavior even
when stabilizing MAPs are highly expressed [63], perhaps
because their binding is regulated by phosphorylation and
other factors.
A detailed cryo-electron microscopy (cryo-EM) analysis has
suggested a possible mechanism by which MAP2/Tau might
reduce catastrophes and thus stabilize microtubules. This
study revealed that the microtubule-binding repeats interact
in an elongated fashion on the outer microtubule lattice,
spanning two tubulin dimers along a single protofilament
rather than bridging adjacent protofilaments [31]. Tau
appeared to show a similar pattern. Several other experi-
ments confirm that MAP2 binds to the outside of micro-
tubules in vivo. First, the projection domain of MAP2 can
regulate microtubule spacing [64]. In addition, an EM study
that compared wild-type to knockout animals suggested that
electron-dense structures on the outer surface of micro-
tubules contain MAP2 [40]. Another cryo-EM analysis sug-
gested that Tau binds to the inner surface of microtubules
[65], but the role of this binding is not yet clear. Tau might
be able to bind to multiple sites, both inside and outside the
microtubule lattice. This idea is consistent with the observa-
tion that Tau has different kinetic properties when bound to
pre-polymerized microtubules than when co-polymerized
with microtubules [66].
MAP2/Tau family proteins can inhibit kinesin- and dynein-
dependent transport along microtubules [67-71]. Observa-
tions  in vitro suggest that this inhibition of microtubule
motor activity occurs by direct competition of MAP2/Tau
proteins with dynein and kinesin for microtubule binding
and also suggest a major role for the projection domain of
the MAP2/Tau proteins in this competition [69,71]. In cells,
overexpression of Tau interferes with kinesin-based trans-
port and alters the balance of plus-end- versus minus-end-
directed transport [67,68]. In vivo, the MAP2 and Tau
projection domains appear to be involved in regulating
microtubule spacing [64]. Such control over microtubule
spacing might facilitate efficient organelle transport.
Binding of MAP2/Tau family proteins to microtubules can
be regulated by phosphorylation of the KXGS motif within
each microtubule-binding repeat. For both MAP2 and Tau,
these motifs are phosphorylated by multiple protein kinases,
including PKA [11] and the microtubule affinity regulating
kinase (MARK) [12], and phosphorylation leads to decreased
affinity for microtubules. Recent evidence also links the Jun
kinase (Jnk) pathway to phosphorylation of MAP2 [72].
Many other protein kinases can phosphorylate MAP2/Tau
proteins in vitro, but for most the identity of the targeted
residues in vivo and the functional consequences of phos-
phorylation remain to be determined. For example, in the
olfactory bulb, a site in the amino-terminal domain of MAP2
is phosphorylated in vivo in a manner that is regulated by
sensory-driven neural activity; the function of this phospho-
rylation is not yet known, however [73]. The regulation of
MAPs, including the MAP2/Tau family, has been summa-
rized in a comprehensive review [74].
Frontiers 
Since their original identification over 20 years ago, classical
structural MAPs of the MAP2/Tau family have been exten-
sively characterized in vitro and in vivo. A major challenge
for further illuminating their function is the vast number of
interaction partners and protein kinases predicted and con-
firmed to phosphorylate MAP2/Tau proteins. Although
some key pathways controlling their activity have been eluci-
dated, a broader and more precise analysis of phosphoryla-
tion and other post-translational modifications is needed to
fully understand MAP2/Tau protein function in signaling
networks controlling the morphogenesis of neurons. Recent
progress in understanding the molecular mechanisms
underlying MAP-microtubule and MAP-actin interactions in
vitro is promising, but biological functions remain elusive.
Future studies will need to correlate the effects of
MAP2/Tau proteins in vivo with molecular knowledge
gained from in vitro analyses. The apparent functional
redundancies and cross-talk with other MAPs and cytoskele-
tal regulators are challenges that will require creative experi-
mental strategies if we are to elucidate the specific functions
of MAP2/Tau family proteins in cytoskeletal organization
and morphological change.
Acknowledgements 
We thank Julia Braga for preparation of the neuronal cultures shown in
Figure 3. This work was supported by grants from the National Institutes
of Health.
References 
1.  Hale CA, de Boer PA: Direct binding of FtsZ to ZipA, an
essential component of the septal ring structure that medi-
ates cell division in E. coli. Cell 1997, 88:175-185. 
The interaction between the bacterial tubulin homolog FtsZ and an
ancestral MAP, ZipA, is described.
2. RayChaudhuri  D:  ZipA is a MAP-Tau homolog and is essential
for structural integrity of the cytokinetic FtsZ ring during
bacterial cell division. EMBO J 1999, 18:2372-2383. 
The functional significance of the ancestral MAP ZipA in bacterial cell
division is described and its relation to MAP2/Tau is proposed.
3.  Hale CA, Rhee AC, de Boer PA: ZipA-induced bundling of FtsZ
polymers mediated by an interaction between C-terminal
domains. J Bacteriol 2000, 182:5153-5166.
204.6 Genome Biology 2004, Volume 6, Issue 1, Article 204 Dehmelt and Halpain http://genomebiology.com/2004/6/1/204
Genome Biology 2004, 6:204The FtsZ interaction domain on ZipA is mapped to its carboxyl termi-
nus, a region unrelated to MAP2/Tau, suggesting that ZipA is not a
functional homolog of MAP2/Tau proteins.
4.  Goedert M, Baur CP, Ahringer J, Jakes R, Hasegawa M, Spillantini
MG, Smith MJ, Hill F: PTL-1, a microtubule-associated protein
with tau-like repeats from the nematode Caenorhabditis
elegans. J Cell Sci 1996, 109:2661-2672. 
Describes the cloning of a MAP2/Tau homolog from C. elegans, expres-
sion analyses, microtubule binding and stabilization experiments, and
overexpression studies.
5.  McDermott JB, Aamodt S, Aamodt E: ptl-1, a Caenorhabditis
elegans gene whose products are homologous to the tau
microtubule-associated proteins. Biochemistry 1996,  35:9415-
9423. 
The first characterization and cloning of the C. elegans MAP2/Tau
homolog.
6.  Heidary G, Fortini ME: Identification and characterization of
the Drosophila tau homolog. Mech Dev 2001, 108:171-178. 
Cloning, expression and subcellular localization studies of the fly
MAP2/Tau homolog are described.
7. Tetraodon Genome Browser
[http://www.genoscope.cns.fr/externe/tetranew/]
8.  Kalcheva N, Albala J, O’Guin K, Rubino H, Garner C, Shafit-Zagardo
B:  Genomic structure of human microtubule-associated
protein 2 (MAP-2) and characterization of additional MAP-2
isoforms. Proc Natl Acad Sci USA 1995, 92:10894-10898. 
The human MAP2 gene is sequenced and analyzed and additional splice
forms are characterized.
9. Himmler  A:  Structure of the bovine tau gene: alternatively
spliced transcripts generate a protein family. Mol Cell Biol
1989, 9:1389-1396. 
The bovine Tau gene is sequenced and analyzed and additional splice
forms are described.
10.  Lewis SA, Wang D, Cowan NJ: Microtubule-associated protein
MAP2 shares a microtubule binding motif with tau protein.
Science 1988, 242:936-939. 
This paper defined the relationship between MAP2 and Tau and
thereby defined the MAP2/Tau family by showing that the two proteins
contain related microtubule-binding domains.
11.  Ozer RS, Halpain S: Phosphorylation-dependent localization of
microtubule-associated protein MAP2c to the actin
cytoskeleton. Mol Biol Cell 2000, 11:3573-3587. 
The phosphorylation of MAP2c by PKA and its relevance for MAP2-
microtubule and MAP2-F-actin interaction is reported.
12.  Drewes G, Trinczek B, Illenberger S, Biernat J, Schmitt-Ulms G,
Meyer HE, Mandelkow EM, Mandelkow E: Microtubule-associated
protein/microtubule affinity-regulating kinase (p110mark).
A novel protein kinase that regulates tau-microtubule
interactions and dynamic instability by phosphorylation at
the Alzheimer-specific site serine 262. J Biol Chem 1995,
270:7679-7688. 
Purification of a novel kinase and characterization of its role in regulat-
ing the microtubule-Tau interaction.
13.  Mukhopadhyay R, Hoh JH: AFM force measurements on micro-
tubule-associated proteins: the projection domain exerts a
long-range repulsive force. FEBS Lett 2001, 505:374-378. 
The authors measured a repulsive, entropic force generated by arrays
of bovine brain MAPs (of which 70% was made up of the MAP2a and
MAP2b isoforms).
14. Uversky  VN:  What does it mean to be natively unfolded? Eur J
Biochem 2002, 269:2-12. 
A review of the basic biochemical characteristics of natively unfolded
proteins, such as the MAP2/Tau proteins.
15.  Malmendal A, Halpain S, Chazin WJ: Nascent structure in the
kinase anchoring domain of microtubule-associated protein
2. Biochem Biophys Res Commun 2003, 301:136-142. 
Characterization of the structural properties of the PKA-RII-binding
domain of MAP2 using limited proteolysis, nuclear magnetic resonance
spectroscopy and circular dichroism spectroscopy.
16.  Roger B, Al Bassam J, Dehmelt L, Milligan RA, Halpain S: MAP2c,
but not tau, binds and bundles F-actin via its microtubule
binding domain. Curr Biol 2004, 14:363-371.
This key paper demonstrates that binding of MAP2/Tau proteins to F-
actin correlates with their ability to induce neurites. It is also the first
paper to measure this binding quantitatively.
17.  Menezes JR, Luskin MB: Expression of neuron-specific tubulin
defines a novel population in the proliferative layers of the
developing telencephalon. J Neurosci 1994, 14:5399-5416. 
The temporal sequence of expression of neuronal markers β-III-tubulin
and MAP2 is analyzed with respect to the behavior of migrating
neurons and dividing neuronal precursors in the developing brain.
18.  Garner CC, Brugg B, Matus A: A 70-kilodalton microtubule-
associated protein (MAP2c), related to MAP2. J Neurochem
1988, 50:609-615. 
The cloning and characterization of the small MAP2 isoform MAP2c is
reported.
19.  Chung WJ, Kindler S, Seidenbecher C, Garner CC: MAP2a, An
alternatively spliced variant of microtubule associated
protein 2. J Neurochem 1996, 66:1273-1281. 
The cloning and characterization of the alternatively spliced adult MAP2
isoform MAP2a is described.
20. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA:
Multiple isoforms of human microtubule-associated protein
tau: sequences and localization in neurofibrillary tangles of
Alzheimer’s disease. Neuron 1989, 3:519-26. 
Characterization using RNAse protection assays of developmentally
regulated isoforms of Tau that differ in the number of microtubule-
binding repeats.
21. Kosik KS, Orecchio LD, Bakalis S, Neve RL: Developmentally
regulated expression of specific tau sequences. Neuron 1989,
2:1389-1397.
Identification of isoforms of Tau and their developmental expression,
using northern blots.
22.  Mavilia C, Couchie D, Nunez J: Diversity of high-molecular-
weight tau proteins in different regions of the nervous
system. J Neurochem 1994, 63:2300-2306. 
An analysis of the regional expression of specific high-molecular-weight
Tau splice forms.
23.  Kotani S, Murofushi H, Maekawa S, Aizawa H, Sakai H: Isolation of
rat liver microtubule-associated proteins. Evidence for a
family of microtubule-associated proteins with molecular
mass of around 200,000 which distribute widely among
mammalian cells. J Biol Chem 1988, 263:5385-5389.
Cloning of MAP4 and analysis of its tissue expression.
24.  Parysek LM, del Cerro M, Olmsted JB: Microtubule-associated
protein 4 antibody: a new marker for astroglia and oligo-
dendroglia. Neuroscience 1985, 15:869-875.
The expression of MAP4 in the murine brain is analyzed.
25. Matus  A:  Microtubule-associated proteins and the determi-
nation of neuronal form. J Physiol (Paris) 1990, 84:134-137. 
A review of the subcellular localization and expression patterns of
MAP2/Tau family proteins.
26.  Hirokawa N, Funakoshi T, Sato-Harada R, Kanai Y: Selective stabi-
lization of tau in axons and microtubule-associated protein
2C in cell bodies and dendrites contributes to polarized
localization of cytoskeletal proteins in mature neurons. J Cell
Biol 1996, 132:667-679. 
The stability of Tau and MAP2c in axons and dendrites was measured
by injection of biotinylated exogenous proteins.
27.  Kanai Y, Hirokawa N: Sorting mechanisms of tau and MAP2 in
neurons: suppressed axonal transit of MAP2 and locally reg-
ulated microtubule binding. Neuron 1995, 14:421-432. 
This study uses mutational analysis to examine the differential sorting of
MAP2 and Tau into axons or dendrites.
28.  Garner CC, Tucker RP, Matus A: Selective localization of mes-
senger RNA for cytoskeletal protein MAP2 in dendrites.
Nature 1988, 336:674-677. 
The localization of MAP2 mRNA to dendrites is reported.
29.  Hirokawa N, Shiomura Y, Okabe S: Tau proteins: the molecular
structure and mode of binding on microtubules. J Cell Biol
1988, 107:1449-1459. 
An ultrastructural analysis of Tau binding to microtubules is reported.
30.  Hirokawa N, Hisanaga S-I, Shiomura Y: MAP2 is a component of
crossbridges between microtubules and neurofilaments in
the neuronal cytoskeleton: quick-freeze, deep-etch immu-
noelectron microscopy and reconstitution studies. J Neurosci
1988, 8:2769-2779. 
The structure of MAP2 in microtubule arrays is characterized using
electron microscopy.
31.  Al Bassam J, Ozer RS, Safer D, Halpain S, Milligan RA: MAP2 and
tau bind longitudinally along the outer ridges of micro-
tubule protofilaments. J Cell Biol 2002, 157:1187-1196. 
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
http://genomebiology.com/2004/6/1/204                                           Genome Biology 2004, Volume 6, Issue 1, Article 204 Dehmelt and Halpain  204.7
Genome Biology 2004, 6:204This paper is the first direct visualization of the structure of MAP2 and
Tau on microtubules at 20 Å resolution using cryo-electron microscopy.
32.  Felgner H, Frank R, Biernat J, Mandelkow EM, Mandelkow E, Ludin B,
Matus A, Schliwa M: Domains of neuronal microtubule-associ-
ated proteins and flexural rigidity of microtubules. J Cell Biol
1997, 138:1067-1075. 
An analysis of the molecular basis of MAP2/Tau-induced flexural rigidity
of microtubules using optical tweezers.
33.  Weisshaar B, Doll T, Matus A: Reorganisation of the microtubu-
lar cytoskeleton by embryonic microtubule-associated
protein 2 (MAP2c). Development 1992, 116:1151-1161. 
The organization of microtubules in non-neuronal cells exogenously
expressing MAP2c.
34.  Lewis SA, Ivanov IE, Lee GH, Cowan NJ: Organization of micro-
tubules in dendrites and axons is determined by a short
hydrophobic zipper in microtubule-associated proteins
MAP2 and tau. Nature 1989, 342:498-505. 
This paper describes microtubule bundle formation in transfected cells
induced by MAP2 and Tau, and a potential mechanism is proposed.
See also [35].
35. Lewis SA, Cowan N: Microtubule bundling. Nature 1990,
345:674.
A letter providing additional data leading to a reinterpretation of the
proposal in [34]. 
36.  Burgin KE, Ludin B, Ferralli J, Matus A: Bundling of microtubules
in transfected cells does not involve an autonomous dimer-
ization site on the MAP2 molecule. Mol Biol Cell 1994, 5:511-
517. 
Given the lack of a high-affinity dimerization site on MAP2c, this article
proposes that microtubule stabilization by itself, through the physical
restraint of the cell borders, is responsible for microtubule bundling.
37.  Takemura R, Okabe S, Umeyama T, Hirokawa N: Polarity orienta-
tion and assembly process of microtubule bundles in noco-
dazole-treated, MAP2c-transfected COS cells. Mol Biol Cell
1995, 6:981-996. 
MAP2c-induced microtubule bundle assembly is analyzed by live-cell
microscopy and the polarity of the resulting bundles is determined by
electron microscopy.
38.  Dehmelt L, Smart FM, Ozer RS, Halpain S: The role of micro-
tubule-associated protein 2c in the reorganization of micro-
tubules and lamellipodia during neurite initiation. J Neurosci
2003, 23:9479-9490. 
Cytoskeletal rearrangements during spontaneous and MAP2c-induced
neurite initiation are characterized using live-cell microscopy and MAP2
deletion analysis.
39.  Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-
Yoshitake R, Takei Y, Noda T, Hirokawa N: Altered micro-
tubule organization in small-calibre axons of mice lacking
tau protein. Nature 1994, 369: 488-491. 
Generation and characterization of a Tau knockout mouse, which has
defects in axon ultrastructure.
40.  Harada A, Teng J, Takei Y, Oguchi K, Hirokawa N: MAP2 is
required for dendrite elongation, PKA anchoring in den-
drites, and proper PKA signal transduction. J Cell Biol 2002,
158:541-549. 
MAP2 knockout mice show defects in dendrite outgrowth and target-
ing of the RII subunit of PKA to dendrites.
41.  DiTella MC, Feiguin F, Carri N, Kosik KS, Caceres A: MAP-
1B/TAU functional redundancy during laminin-enhanced
axonal growth. J Cell Sci 1996, 109:467-477.
The results of inhibition of MAP1B and Tau expression by antisense
oligonucleotides suggests functional redundancy of the two proteins.
42.  Takei Y, Teng J, Harada A, Hirokawa N: Defects in axonal elon-
gation and neuronal migration in mice with disrupted tau
and map1b genes. J Cell Biol 2000, 150:989-1000. 
This paper reports the crossing of MAP1B and Tau knockout animals;
anatomical analysis shows defects in axon outgrowth and neuronal
migration.
43.  Teng J, Takei Y, Harada A, Nakata T, Chen J, Hirokawa N: Syner-
gistic effects of MAP2 and MAP1B knockout in neuronal
migration, dendritic outgrowth, and microtubule organiza-
tion. J Cell Biol 2001, 155:65-76. 
The first MAP2 knockout mouse is described. Crossing of MAP1B and
MAP2 knockout animals leads to defects in dendrite outgrowth and
neuronal migration.
44.  Obar RA, Dingus J, Bayley H, Vallee RB: The RII subunit of
cAMP-dependent protein kinase binds to a common amino-
terminal domain in microtubule-associated proteins 2A, 2B,
and 2C. Neuron 1989, 3:639-645. 
Mapping of the PKA-RII-binding domain on MAP2 is reported.
45. Lee VM, Goedert M, Trojanowski JQ: Neurodegenerative
tauopathies. Annu Rev Neurosci 2001, 24:1121-1159. 
This review gives a general overview of tauopathies, diseases thought
to be linked to alterations in Tau behavior.
46.  Gamblin TC, Berry RW, Binder LI: Modeling tau polymerization
in vitro: a review and synthesis. Biochemistry 2003,  42:15009-
15017. 
A review of biochemical analyses of Tau polymerization and its rele-
vance for tauopathies.
47. Geschwind  DH:  Tau phosphorylation, tangles, and neuro-
degeneration: the chicken or the egg? Neuron 2003, 40:457-460. 
A review of the role of Tau phosphorylation in neurodegenerative
diseases.
48.  Goedert M, Ghetti B, Spillantini MG: Tau gene mutations in
frontotemporal dementia and parkinsonism linked to chro-
mosome 17 (FTDP-17). Their relevance for understanding
the neurogenerative process. Ann NY Acad Sci 2000, 920:74-83. 
The role of Tau mutations in the specific tauopathy FTDP-17 is
reviewed.
49.  Chapin SJ, Bulinski JC: Non-neuronal 210 x 10(3) Mr micro-
tubule-associated protein (MAP4) contains a domain
homologous to the microtubule-binding domains of neu-
ronal MAP2 and tau. J Cell Sci 1991, 98:27-36. 
This paper reports the cloning of MAP4 and comparison of its
sequence with MAP2 and Tau.
50.  Nguyen HL, Chari S, Gruber D, Lue CM, Chapin SJ, Bulinski JC:
Overexpression of full- or partial-length MAP4 stabilizes
microtubules and alters cell growth. J Cell Sci 1997, 110:281-
294. 
Stabilization of cellular microtubules by MAP4 is reported.
51.  Ookata K, Hisanaga S, Bulinski JC, Murofushi H, Aizawa H, Itoh TJ,
Hotani H, Okumura E, Tachibana K, Kishimoto T: Cyclin B inter-
action with microtubule-associated protein 4 (MAP4)
targets p34cdc2 kinase to microtubules and is a potential
regulator of M-phase microtubule dynamics. J Cell Biol 1995,
128:849-862.
This study reports an interaction of MAP4 with cyclin B and discusses
its potential functional relevance for regulation of microtubules during
mitosis.
52.  Wang XM, Peloquin JG, Zhai Y, Bulinski JC, Borisy GG: Removal of
MAP4 from microtubules in vivo produces no observable
phenotype at the cellular level. J Cell Biol 1996, 132:345-357. 
In cultured cells, MAP4 was blocked using a function-blocking antibody.
No phenotype was detected, suggesting that MAP4 is a component of
a functionally redundant system.
53.  Mangan ME, Olmsted JB: A muscle-specific variant of micro-
tubule-associated protein 4 (MAP4) is required in myogene-
sis. Development 1996, 122:771-781.
Defects in myogenesis in a muscle cell line lacking the muscle-specific
MAP4 isoform were found.
54.  Papasozomenos SC, Binder LI: Microtubule-associated protein 2
(MAP2) is present in astrocytes of the optic nerve but
absent from astrocytes of the optic tract. J Neurosci 1986,
6:1748-1756. 
A report of the expression of MAP2 in specific astrocytes.
55.  Vouyiouklis DA, Brophy PJ: Microtubule-associated proteins in
developing oligodendrocytes: transient expression of a
MAP2c isoform in oligodendrocyte precursors. J Neurosci Res
1995, 42:803-817. 
The expression of the early neuronal MAP2 isoform MAP2c is analyzed
during oligodendrocyte differentiation.
56.  Loveland KL, Herszfeld D, Chu B, Rames E, Christy E, Briggs LJ,
Shakri R, de Kretser DM, Jans DA: Novel low molecular weight
microtubule-associated protein-2 isoforms contain a func-
tional nuclear localization sequence. J Biol Chem 1999,
274:19261-19268. 
The discovery of nuclear MAP2 isoforms containing an alternatively
spliced nuclear localization sequence.
57.  LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski RP, Binder LI:
Functional implications for the microtubule-associated
protein tau: localization in oligodendrocytes. Proc Natl Acad Sci
USA 1995, 92:10369-10373. 
Expression of Tau in oligodendrocytes.
58.  Muller R, Heinrich M, Heck S, Blohm D, Richter-Landsberg C:
Expression of microtubule-associated proteins MAP2 and
204.8 Genome Biology 2004, Volume 6, Issue 1, Article 204 Dehmelt and Halpain http://genomebiology.com/2004/6/1/204
Genome Biology 2004, 6:204tau in cultured rat brain oligodendrocytes. Cell Tissue Res 1997,
288:239-249. 
Expression of both Tau and MAP2 was analyzed in oligodendrocytes
and compared to neurons.
59.  Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J:
Process outgrowth of oligodendrocytes is promoted by
interaction of fyn kinase with the cytoskeletal protein tau.
J Neurosci 2002, 22:698-707. 
The role of an interaction between Fyn and Tau is analyzed.
60.  Gamblin TC, Nachmanoff K, Halpain S, Williams RCJ: Recombi-
nant microtubule-associated protein 2c reduces the
dynamic instability of individual microtubules. Biochemistry
1996, 35:12576-12586. 
A study of the effect of purified, recombinant MAP2c on microtubule
dynamics in vitro.
61.  Panda D, Samuel JC, Massie M, Feinstein SC, Wilson L: Differential
regulation of microtubule dynamics by three- and four-
repeat tau: implications for the onset of neurodegenerative
disease. Proc Natl Acad Sci USA 2003, 100:9548-9553. 
The effects of different Tau isoforms on microtubule dynamics are
reported and the relevance for neurodegenerative diseases is dis-
cussed.
62.  Ichihara K, Kitazawa H, Iguchi Y, Hotani H, Itoh TJ: Visualization of
the stop of microtubule depolymerization that occurs at the
high-density region of microtubule-associated protein 2
(MAP2). J Mol Biol 2001, 312:107-118. 
An analysis of the clustering of MAP2 on microtubules and its relevance
for microtubule dynamics.
63.  Kaech S, Ludin B, Matus A: Cytoskeletal plasticity in cells
expressing neuronal microtubule-associated proteins.
Neuron 1996, 17:1189-1199. 
The short- and long-term dynamics of microtubules in the presence of
MAP2 or Tau are characterized.
64.  Chen J, Kanai Y, Cowan NJ, Hirokawa N: Projection domains of
MAP2 and tau determine spacings between microtubules in
dendrites and axons. Nature 1992, 360:674-677. 
Characterization of the role of MAP2 and Tau projection domains in
microtubule spacing in axons and dendrites.
65.  Kar S, Fan J, Smith MJ, Goedert M, Amos LA: Repeat motifs of tau
bind to the insides of microtubules in the absence of taxol.
EMBO J 2003, 22:70-77. 
A cryo-EM study that reports the binding of Tau to the inner surface of
microtubules.
66.  Makrides V, Massie MR, Feinstein SC, Lew J: Evidence for two dis-
tinct binding sites for tau on microtubules. Proc Natl Acad Sci
USA 2004, 101:6746-6751. 
Tau binding to preassembled microtubules is compared to Tau binding
after co-assembly with microtubules. The results suggest that Tau can
bind microtubules in two distinct ways.
67.  Trinczek B, Ebneth A, Mandelkow EM, Mandelkow E: Tau regu-
lates the attachment/detachment but not the speed of
motors in microtubule-dependent transport of single vesi-
cles and organelles. J Cell Sci 1999, 112:2355-2367. 
The effect of Tau on dynein- and kinesin-dependent cellular transport
processes is reported.
68.  Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Man-
delkow E: Overexpression of tau protein inhibits kinesin-
dependent trafficking of vesicles, mitochondria, and
endoplasmic reticulum: implications for Alzheimer’s
disease. J Cell Biol 1998, 143:777-794. 
The effect of Tau overexpression on kinesin-dependent transport
processes is reported.
69.  Hagiwara H, Yorifuji H, Sato-Yoshitake R, Hirokawa N: Competi-
tion between motor molecules (kinesin and cytoplasmic
dynein) and fibrous microtubule-associated proteins in
binding to microtubules. J Biol Chem 1994, 269:3581-3589. 
A biochemical analysis of competition between MAPs and microtubule
motors.
70.  Seitz A, Kojima H, Oiwa K, Mandelkow EM, Song YH, Mandelkow E:
Single-molecule investigation of the interference between
kinesin, tau and MAP2c. EMBO J 2002, 21:4896-4905. 
Single-molecule analysis of kinesin movements on microtubules and the
influence of Tau on movement parameters are measured.
71.  Lopez LA, Sheetz MP: Steric inhibition of cytoplasmic dynein and
kinesin motility by MAP2. Cell Motil Cytoskeleton 1993, 24: 1-16. 
The effect of MAP2 and Tau on dynein and kinesin activity is measured
using microtubule sliding assays.
72.  Chang L, Jones Y, Ellisman MH, Goldstein LS, Karin M: JNK1 is
required for maintenance of neuronal microtubules and
controls phosphorylation of microtubule-associated pro-
teins. Dev Cell 2003, 4:521-533. 
This report shows a reduced association of MAP2 with microtubules in
Jnk1 knockout mice.
73.  Philpot BD, Lim JH, Halpain S, Brunjes PC: Experience-dependent
modifications in MAP2 phosphorylation in rat olfactory
bulb. J Neurosci 1997, 17:9596-9604. 
A report of activity-dependent phosphorylation of a specific site on
MAP2.
74.  Cassimeris L, Spittle C: Regulation of microtubule-associated
proteins. Int Rev Cytol 2001, 210:163-226. 
This substantial review summarizes the activity and regulation of animal
cell MAPs, including Tau and MAP2.
75.  LocusLink [http://www.ncbi.nlm.nih.gov/]
76. Felsenstein  J:  PHYLIP: Phylogenetic Inference Package. 3.6a edition.
Seattle: Department of Genetics, University of Washington; 2002. 
77.  Kim H, Binder LI, Rosenbaum JL: The periodic association of
MAP2 with brain microtubules in vitro. J Cell Biol 1979, 80:266-
276. 
A highly enriched MAP2 fraction was prepared from calf neurotubules
and a MAP2-microtubule interaction and microtubule stabilization were
found.
78.  Lim RWL, Halpain S: Regulated association of microtubule-
associated protein 2 (MAP2) with Src and Grb2: evidence
for MAP2 as a scaffolding protein. J Biol Chem 2000, 275:20578-
20587. 
A report of the interaction of MAP2 with Src and Grb2 and regulation
of this interaction by Erk2.
79.  Zamora-Leon SP, Lee G, Davies P, Shafit-Zagardo B: Binding of
Fyn to MAP-2c through an SH3 binding domain. Regulation
of the interaction by ERK2. J Biol Chem 2001, 276:39950-39958. 
A report of the interaction of Fyn with MAP2c and the regulation of
this interaction by Erk2.
80.  Leterrier JF, Liem RK, Shelanski ML: Interactions between neu-
rofilaments and microtubule-associated proteins: a possible
mechanism for intraorganellar bridging. J Cell Biol 1982,
95:982-986. 
An interaction of MAP2 with neurofilaments is reported.
81.  Davare MA, Dong F, Rubin CS, Hell JW: The A-kinase anchor
protein MAP2B and cAMP-dependent protein kinase are
associated with class C L-type calcium channels in neurons. J
Biol Chem 1999, 274:30280-30287. 
This paper describes a role for MAP2 as an AKAP (A-kinase anchoring
protein) for class C L-type calcium channels.
82.  Rehbein M, Kindler S, Horke S, Richter D: Two trans-acting rat-
brain proteins, MARTA1 and MARTA2, interact specifically
with the dendritic targeting element in MAP2 mRNAs. Brain
Res Mol Brain Res 2000, 79:192-201. 
Two proteins were cloned that interact specifically with MAP2 mRNA
elements responsible for dendritic targeting.
83.  Butner KA, Kirschner MW: Tau protein binds to microtubules
through a flexible array of distributed weak sites. J Cell Biol
1991, 115:717-730. 
Mapping of the microtubule binding site of Tau.
84.  Lee G, Newman T, Gard DL, Band H, Panchamoorthy G: Tau
interacts with src-family non-receptor tyrosine kinases. J Cell
Sci 1998, 111:3167-3177. 
The interaction between Fyn and Tau is reported.
85.  Takashima A, Murayama M, Murayama O, Kohno T, Honda T, Yasu-
take K, Nihonmatsu N, Mercken M, Yamaguchi H, Sugihara S,
Wolozin B: Presenilin 1 associates with glycogen synthase
kinase-3beta and its substrate tau. Proc Natl Acad Sci USA 1998,
95:9637-9641. 
A report of the interaction of Presenilin 1 with GSK3-beta and Tau.
86.  Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong
LM, Jakes R, Huang DY, Pericak-Vance M, Schmechel D, Roses AD:
Isoform-specific interactions of apolipoprotein E with
microtubule-associated protein tau: implications for
Alzheimer disease. Proc Natl Acad Sci USA 1994, 91:11183-11186. 
A report of the interaction between ApoE and Tau.
87.  Baudier J, Mochly-Rosen D, Newton A, Lee SH, Koshland DE Jr,
Cole RD: Comparison of S100b protein with calmodulin:
interactions with melittin and microtubule-associated tau
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
http://genomebiology.com/2004/6/1/204                                           Genome Biology 2004, Volume 6, Issue 1, Article 204 Dehmelt and Halpain  204.9
Genome Biology 2004, 6:204proteins and inhibition of phosphorylation of tau proteins by
protein kinase C. Biochemistry 1987, 26:2886-2893. 
The interaction between S100b and Tau is reported.
204.10 Genome Biology 2004, Volume 6, Issue 1, Article 204 Dehmelt and Halpain http://genomebiology.com/2004/6/1/204
Genome Biology 2004, 6:204